JPH02309247A - Vasopressin detection sensor - Google Patents
Vasopressin detection sensorInfo
- Publication number
- JPH02309247A JPH02309247A JP1130831A JP13083189A JPH02309247A JP H02309247 A JPH02309247 A JP H02309247A JP 1130831 A JP1130831 A JP 1130831A JP 13083189 A JP13083189 A JP 13083189A JP H02309247 A JPH02309247 A JP H02309247A
- Authority
- JP
- Japan
- Prior art keywords
- vasopressin
- pasopressin
- monoclonal antibody
- electrode
- drain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000001514 detection method Methods 0.000 title claims abstract description 9
- GXBMIBRIOWHPDT-UHFFFAOYSA-N Vasopressin Natural products N1C(=O)C(CC=2C=C(O)C=CC=2)NC(=O)C(N)CSSCC(C(=O)N2C(CCC2)C(=O)NC(CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(CCC(N)=O)NC(=O)C1CC1=CC=CC=C1 GXBMIBRIOWHPDT-UHFFFAOYSA-N 0.000 title abstract description 11
- 102000002852 Vasopressins Human genes 0.000 title abstract description 11
- 108010004977 Vasopressins Proteins 0.000 title abstract description 11
- KBZOIRJILGZLEJ-LGYYRGKSSA-N argipressin Chemical compound C([C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@@H](C(N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)=O)N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)C1=CC=CC=C1 KBZOIRJILGZLEJ-LGYYRGKSSA-N 0.000 title abstract description 11
- 229960003726 vasopressin Drugs 0.000 title abstract description 11
- 239000012528 membrane Substances 0.000 claims description 21
- 238000005259 measurement Methods 0.000 claims description 11
- 238000006243 chemical reaction Methods 0.000 claims description 6
- 230000005669 field effect Effects 0.000 claims description 5
- 239000000427 antigen Substances 0.000 claims description 4
- 239000011248 coating agent Substances 0.000 claims 1
- 238000000576 coating method Methods 0.000 claims 1
- 230000005426 magnetic field effect Effects 0.000 claims 1
- 239000000758 substrate Substances 0.000 abstract description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 abstract description 4
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 abstract description 4
- 229910052710 silicon Inorganic materials 0.000 abstract description 4
- 239000010703 silicon Substances 0.000 abstract description 4
- 239000011347 resin Substances 0.000 abstract description 3
- 229920005989 resin Polymers 0.000 abstract description 3
- 229910052681 coesite Inorganic materials 0.000 abstract description 2
- 229910052906 cristobalite Inorganic materials 0.000 abstract description 2
- 230000003647 oxidation Effects 0.000 abstract description 2
- 238000007254 oxidation reaction Methods 0.000 abstract description 2
- 239000000377 silicon dioxide Substances 0.000 abstract description 2
- 235000012239 silicon dioxide Nutrition 0.000 abstract description 2
- 229910052682 stishovite Inorganic materials 0.000 abstract description 2
- 229910052905 tridymite Inorganic materials 0.000 abstract description 2
- 229910052581 Si3N4 Inorganic materials 0.000 abstract 1
- 238000005229 chemical vapour deposition Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 238000007740 vapor deposition Methods 0.000 abstract 1
- 239000000126 substance Substances 0.000 description 8
- 108091006146 Channels Proteins 0.000 description 4
- 238000003127 radioimmunoassay Methods 0.000 description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 150000002500 ions Chemical class 0.000 description 3
- 230000005855 radiation Effects 0.000 description 3
- 208000024827 Alzheimer disease Diseases 0.000 description 2
- 239000004593 Epoxy Substances 0.000 description 2
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 2
- 206010039966 Senile dementia Diseases 0.000 description 2
- 125000003172 aldehyde group Chemical group 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 2
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000004811 liquid chromatography Methods 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 description 1
- HMJBXEZHJUYJQY-UHFFFAOYSA-N 4-(aminomethyl)octane-1,8-diamine Chemical compound NCCCCC(CN)CCCN HMJBXEZHJUYJQY-UHFFFAOYSA-N 0.000 description 1
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
- 229920002284 Cellulose triacetate Polymers 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- 108010075750 P-Type Calcium Channels Proteins 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- NNLVGZFZQQXQNW-ADJNRHBOSA-N [(2r,3r,4s,5r,6s)-4,5-diacetyloxy-3-[(2s,3r,4s,5r,6r)-3,4,5-triacetyloxy-6-(acetyloxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6s)-4,5,6-triacetyloxy-2-(acetyloxymethyl)oxan-3-yl]oxyoxan-2-yl]methyl acetate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](OC(C)=O)[C@H]1OC(C)=O)O[C@H]1[C@@H]([C@@H](OC(C)=O)[C@H](OC(C)=O)[C@@H](COC(C)=O)O1)OC(C)=O)COC(=O)C)[C@@H]1[C@@H](COC(C)=O)O[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]1OC(C)=O NNLVGZFZQQXQNW-ADJNRHBOSA-N 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- 210000004720 cerebrum Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 229960003638 dopamine Drugs 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 210000003016 hypothalamus Anatomy 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 210000002963 paraventricular hypothalamic nucleus Anatomy 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical group CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 239000012857 radioactive material Substances 0.000 description 1
- 229910052594 sapphire Inorganic materials 0.000 description 1
- 239000010980 sapphire Substances 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229940076279 serotonin Drugs 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 210000004377 supraoptic nucleus Anatomy 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Landscapes
- Investigating Or Analyzing Materials By The Use Of Electric Means (AREA)
Abstract
Description
【発明の詳細な説明】
産業上の利用分野
本発明は、アセチルコリン、ドーパミン、セロトニン、
γ−アミノ酪酸、グルタミン酸等の他の物質が混在して
もパゾプレッシンのみに感じ、老人痴呆関連物質の一つ
として注目され、大脳の視床下部の室傍核や視索上核に
存在しているパゾプレッシンの濃度を検出するバゾプレ
ソンン検出センサに関するものである。DETAILED DESCRIPTION OF THE INVENTION Field of Industrial Application The present invention is applicable to acetylcholine, dopamine, serotonin,
Even when other substances such as γ-aminobutyric acid and glutamic acid are present, only pasopressin is felt, and it has attracted attention as one of the substances related to senile dementia, and is present in the paraventricular nucleus and supraoptic nucleus of the hypothalamus of the cerebrum. The present invention relates to a vasopressin detection sensor that detects the concentration of vasopressin.
従来の技術
老人痴呆関連物質の一つとして注目されているバゾブレ
yシンの検出は、従来、分離・定量法として液体クロマ
トグラフィーと放射性免疫分析法とを併用したり、ある
いは放射性免疫検定法(ラジオイムノアッセイRIA)
によシ行われていた。Conventional technology The detection of vasobrecin, which has attracted attention as a substance related to senile dementia, has conventionally been performed using a combination of liquid chromatography and radioimmunoassay as separation and quantitative methods, or radioimmunoassay (radioimmunoassay). Immunoassay RIA)
It was done well.
液体クロマトグラフィーのカラムに組み合わせて、特定
物質が来た時にそれのみに対応して反応する抗原・抗体
反応を利用して特定物質の吸着を行ない、その物質を同
位元素でマークし、その放射量の強さから定量を行なう
ものである。マークする同位元素は35S、 125
工等が多く使われている。When combined with a liquid chromatography column, a specific substance is adsorbed using an antigen/antibody reaction that reacts only when a specific substance arrives, and the substance is marked with an isotope to determine its radiation amount. Quantification is performed based on the strength of The isotope to mark is 35S, 125
A lot of tools are used.
発明が解決しようとする課題
しかし、上述した方法は生体から体液を取シ出して分離
・定量するものであり、体内の局所情報を直接計測した
ものではない。また放射量検出のために装置(液体シン
テレーンヨンカウンタ、r線スヘクトロメトリ、シンテ
レーションヵクンタ等)が大型であること、 Sの半
減期は87.9日、125Iの半減期は60 日で安定
性に時間がかかること、検出器の精度が低いこと、照射
物質や放射性物質の取扱い施設が要すること、厳密に放
射線に対する保護が必要なこと、取扱い者が限られるこ
と、トータルコストが高いという問題があった。Problems to be Solved by the Invention However, the above-mentioned method involves extracting, separating and quantifying body fluid from a living body, and does not directly measure local information within the body. In addition, the equipment used to detect the radiation amount (liquid syntellinometer, r-ray hectometry, scintillation capacunter, etc.) is large, and the half-life of S is 87.9 days, and that of 125I is stable at 60 days. Problems include: time-consuming detection, low accuracy of detectors, need for facilities to handle irradiated materials and radioactive materials, strict protection against radiation, limited number of people who can handle them, and high total cost. was there.
本発明は従来法に述べた欠点を解消するために、バゾプ
レッシンモノクローナル抗体の作用により、バゾプレッ
シンのみと反応して、その濃度に比例するパゾプレッシ
ンモノクローナル抗体固定化膜を形成せしめ、それによ
る膜電位変化をポテンションメ)!I−iにより、簡単
に測定ができる小型でかつ、安価なパゾプレッシン検出
用I 8FETセンサを提供するものである。なお、こ
の検出センサはインビボ(in vivo (生体
内)〕においても測測定能である。In order to eliminate the drawbacks of the conventional method, the present invention uses the action of a vasopressin monoclonal antibody to react only with vasopressin to form a vasopressin monoclonal antibody-immobilized membrane proportional to its concentration, thereby changing the membrane potential. Potential)! I-i provides a compact and inexpensive I8FET sensor for detecting pasopressin that can be easily measured. Note that this detection sensor is also capable of measuring in vivo.
課題を解決するための手段
上記目的を達成するため、本発明の技術的解決手段は、
一つの基板上に抗体・抗原反応によって膜電位が変わる
パゾプレッンンモノクローナル抗体を固定化した膜で覆
った測定ISFET (イオン感応性電界効果トランジ
スタ)と固定化膜をつけない参照ISFETの2つを用
意し、環境温度を補償することによって、純粋にパゾプ
レッシンのみに感じて、その濃度を指示するようにした
ものである。Means for Solving the Problems In order to achieve the above object, the technical solution of the present invention is as follows:
A measurement ISFET (ion-sensitive field effect transistor) covered with a membrane immobilized with a Pazoprene monoclonal antibody whose membrane potential changes depending on the antibody/antigen reaction on one substrate, and a reference ISFET without an immobilized membrane are installed on one substrate. By preparing it and compensating for the environmental temperature, it senses only pasopressin and indicates its concentration.
作 用
本発明はいろいろな物質が共存していてもパゾプレッシ
ンのみがバゾプレッシンモノクローナル抗体によって抗
体・抗原反応し、パゾプレッシンモノクローナル抗体固
定化膜が形成する。膜の内部では外部に存在するパゾプ
レッシンの濃度に応じて膜電位が変化し、そのためにゲ
ート電圧が変化して、FETのチャンネルに電子が誘起
され、ソース・ドレイン間に電流が流れ、この電流は外
部溶液の膜電位や温度が変わっても変化を受けるので、
外部溶液の膜電位や温度のみに感じるISFETを並列
に設けることによシプッシュプル差動回路によってそれ
を補償して溶液中のパゾプレッシンのみの濃度を検出す
るものである。Effects According to the present invention, even if various substances coexist, only pasopressin undergoes an antibody-antigen reaction with the vasopressin monoclonal antibody, and a pasopressin monoclonal antibody-immobilized membrane is formed. Inside the membrane, the membrane potential changes depending on the concentration of pasopressin present outside, which changes the gate voltage and induces electrons in the channel of the FET, causing a current to flow between the source and drain. It is subject to changes even if the membrane potential or temperature of the external solution changes.
By installing ISFETs in parallel that sense only the membrane potential and temperature of the external solution, this is compensated for by a push-pull differential circuit and the concentration of only pasopressin in the solution is detected.
実施例 以下に本発明の実施例を図面を用いて詳細に説明する。Example Embodiments of the present invention will be described in detail below with reference to the drawings.
第1図(a)は測定ISFET (イオン感応性電界
効果トランジスタ)を上から見た図で、同図(b)は(
a)の1−1’における断面図である。1はP−型シリ
コン基板である。2.2はそれにリンを拡散によりドー
プして作ったドレイン、ソースn+領域である。3はP
−型のチャンネル部分である。Figure 1 (a) is a top view of the measured ISFET (ion-sensitive field effect transistor), and Figure 1 (b) is (
It is a sectional view taken along 1-1' of a). 1 is a P-type silicon substrate. 2.2 is a drain and source n+ region made by doping it with phosphorus by diffusion. 3 is P
-It is the channel part of the mold.
4は先端のゲート部分以外の表面に形成されたホウ素を
拡散したP+のチャンネルストッパーである。5はドレ
イン電極でAu−Crを蒸着したものである。6はソー
ス電極でAu−Crを蒸着したものである。5.6はそ
れぞれドレイン、ソース電極AI!端子である。7は加
熱酸化によって素子表面に形成した5iOz被膜である
。9はゲート部分以外をモールド化したエポキシとシリ
コンの混合樹脂である。10はパゾプレッシンのみに反
応するパゾプレッシンモノクローナル抗体である。4 is a P+ channel stopper in which boron is diffused and formed on the surface other than the gate portion at the tip. 5 is a drain electrode on which Au-Cr is deposited. 6 is a source electrode on which Au--Cr is deposited. 5.6 are the drain and source electrodes AI! It is a terminal. 7 is a 5iOz film formed on the element surface by thermal oxidation. 9 is a mixed resin of epoxy and silicon which is molded except for the gate portion. 10 is a pasopressin monoclonal antibody that reacts only with pasopressin.
第2図は参照pH−ISFET(イオン感応性電界効果
トランジスタ)の構成を示し、第2図(a)は平面図、
第2図(b)は同図(a)の1−1′における断面図で
ある。参照pH−ISFETは第1図に示した測定pH
−ISFETとほぼ同一の構成をしており、ゲート部に
固定化膜が設けられていない点で異なる。FIG. 2 shows the configuration of a reference pH-ISFET (ion-sensitive field effect transistor), and FIG. 2(a) is a plan view,
FIG. 2(b) is a sectional view taken along line 1-1' of FIG. 2(a). The reference pH-ISFET is at the measured pH shown in Figure 1.
- It has almost the same configuration as the ISFET, but differs in that no immobilization film is provided in the gate part.
次に、パゾブレッンンモノクローナル抗体を膜に固定化
する方法を述べる。Next, a method for immobilizing the Pazobrelen monoclonal antibody on a membrane will be described.
(3−アミノプロピル)トリエトキンシランと水との1
0=1溶液にIMHcJを加えてp)(’yに調整し、
水浴上で50℃に加熱した浴中にゲート電極部分を2h
r浸漬反応させて5iaN4 を化学修飾する。化学修
飾させたゲート電極をセルローズトリアセテート250
mg をジクロメタン10mJ?に溶解し、さらに50
チのグルタルアルデヒド100μlと4−アミノメチル
−1,8−オクタンジアミン500μlを加えた溶液に
浸漬して後、デシケータ中で1日保存して架橋反応を進
行させる。さらに1%のグルタルアルデヒド溶液と室温
で1hr反応させて有機皮膜の表面にアルデヒド基を導
入し、pH7のリン酸緩衝液で充分洗浄してからサファ
イア基板FETゲートを4℃のパゾプレッシンモノクロ
ーナル抗体を分散させた飽和溶液の中に浸漬して、アミ
ノ基とアルデヒド基を置換することによシ、パゾプレッ
シンモノクローナル抗体を膜に固定する。1 of (3-aminopropyl)triethquinsilane and water
Add IMHcJ to 0=1 solution and adjust to p)('y,
Place the gate electrode part in a water bath heated to 50℃ for 2 hours.
5iaN4 is chemically modified by r-soaking reaction. The chemically modified gate electrode is made of cellulose triacetate 250.
mg to dichloromethane 10mJ? and further 50
After immersing in a solution containing 100 μl of glutaraldehyde and 500 μl of 4-aminomethyl-1,8-octanediamine, the sample was stored in a desiccator for 1 day to allow the crosslinking reaction to proceed. Furthermore, aldehyde groups were introduced onto the surface of the organic film by reacting it with a 1% glutaraldehyde solution for 1 hour at room temperature, and after thorough washing with a pH 7 phosphate buffer, the sapphire substrate FET gate was coated with pasopressin monoclonal antibody at 4°C. The pasopressin monoclonal antibody is immobilized on the membrane by substituting the amino group with the aldehyde group by immersing it in a saturated dispersed solution.
第3図は、パゾプレッシン検出用I S FETの測定
回路図で、定電流源20により、測定l5FBT11
に常に一定のドレイン電流Idが流れ、別の電流源18
により測定ISFETIIのソース、ドレイン間に一定
電圧Vd=RIlが印加されている。FIG. 3 is a measurement circuit diagram of I S FET for detecting pasopressin.
A constant drain current Id always flows through another current source 18.
A constant voltage Vd=RIl is applied between the source and drain of the measured ISFET II.
溶液中の膜電位により界面電位が変化しても、測定IS
FETIIのId、Vdが変化できないため、ソース、
ドレイン間の電位が共に界面電位変化分だけ変わり、v
Outlにその変化が出力される。溶液の濃度変化や均
一な膜電位変化に対する応答特性を:くするために、同
様にして参照ISFET 12によるVout 2を出
力させる。24はその差を取るための差動増幅器である
。Even if the interfacial potential changes due to the membrane potential in the solution, the measurement IS
Since Id and Vd of FETII cannot be changed, the source,
The potential between the drains changes by the amount of change in the interfacial potential, and v
The change is output to Outl. In order to improve response characteristics to changes in solution concentration and uniform membrane potential changes, the reference ISFET 12 outputs Vout 2 in the same manner. 24 is a differential amplifier for taking the difference.
測定方法は、まず微小なマイクロシリンジをセットし、
この中に体液をわずか(量は0.5μl)に取り出して
、バゾプレソシンモノクローナル抗体を固定化した測定
ISFETIIと固定化しない裸のISFET(参照I
SFET ) 12とAgの表面を塩化物化したAg
/Ag C1基準極13の3電極を液絡させる。オペア
ンプ14.15.16.17 によって両ISFET
u、12に常に10μAのドレイン電流を流し、ソース
・ドレイン間に電流源18.19.20.21及び抵抗
22.23によシ一定の直流電圧(1〜2v)がかかる
ようにする。そうすると差動測定回路により、測定溶液
の温度変化や膜電位変化が補償されて、バゾブレッンン
の濃度のみに依存する出力が差動増幅器24により得ら
れ、第4図のような出力結果が得られる。To measure, first set up a tiny microsyringe,
A small amount of body fluid (volume: 0.5 μl) was taken out into this solution, and a measurement ISFET II on which vasopressosin monoclonal antibody was immobilized and a bare ISFET without immobilization (Reference I
SFET) 12 and Ag with chloride on the surface
/Ag The three electrodes of the C1 reference electrode 13 are brought into liquid junction. Both ISFETs by op amp 14.15.16.17
A drain current of 10 .mu.A is always passed through U and 12, and a constant DC voltage (1 to 2 V) is applied between the source and drain through the current source 18, 19, 20, 21 and resistor 22.23. Then, the temperature change and membrane potential change of the measurement solution are compensated for by the differential measurement circuit, and the differential amplifier 24 obtains an output that depends only on the concentration of bazobrene, resulting in the output result shown in FIG. 4.
発明の効果
以上のように、本発明の効果としては、一つの基板上に
パゾブレッンンモノクローナル抗体を固定化した膜で覆
った測定I 5FETと固定化膜をっけない参照JSF
ETの2つを用意し、従来では得られなかった小をでか
つ測定が簡単で、安価で、溶液の温度や膜電位に影響さ
れず、温度補償が不要で、いろいろな種類の物質が共存
していても、このパゾプレッシンモノクローナル抗体に
は選択性があるので、パゾプレッシンしか作用しない検
出センサを提供することができる。なお、この検出セン
サはインビボ(in vivo (生体内の局所情報を
その1まソース・ドレイン間の電流で計測することがで
きる)〕においても測測定能である。Effects of the Invention As described above, the effects of the present invention are as follows: Measurement I 5FET covered with a membrane on which Pazobrene monoclonal antibody is immobilized on one substrate and reference JSF without the immobilized membrane.
Two types of ET have been prepared, and the measurement is easy and inexpensive, with a small size that could not be obtained conventionally, and it is not affected by the temperature of the solution or membrane potential, does not require temperature compensation, and can coexist with various types of substances. However, since this pasopressin monoclonal antibody has selectivity, it is possible to provide a detection sensor that only acts on pasopressin. Note that this detection sensor is also capable of measuring in vivo (local information within the living body can be measured by the current between the source and drain).
第1図(a)は本発明の一実施例におけるバゾブレノシ
ン測定用ISFETの平面図、第1図(b)は同図(a
)の1−1’面における断面図、第2図(a)はパゾプ
レッシン参照用l8FETの平面図、第2図(b)は同
図(a)の1−1’面における断面図、第3図は本実施
例のパゾプレッシン検出用I 8 FETの測定回路図
、第4図はバゾブレノシンの濃度とソース・ドレイン間
の電流の関係である。
工・・P−型シリコン、2・・ドレインn 領域、2′
・・・ソースn 領域、3・・P−型のチャンネル、4
・・チャンネルストッパー(P)、5・・・ドレイン電
極、5′・ドレイン電極Al 端子、6・・・ソース電
極、6′8.・ソース電極AJ端子、7・・・SiO2
,8・・・Si3N4.9・・・エポキシとシリコンの
混合樹脂、10・・・パゾプレッシンモノクローナル抗
体固体化膜、11 測定pH−FET、12・・・参
照p1イーFET。
13 ・Ag/Ag (J基準極、24・・・差動増
幅器。
代理人の氏名 弁理士 粟 野 重 孝 ほか1名第1
図
(Q、)
10 ?i#C騰
第2図
第3図
1δ
ISF丘T/2
第4図
PP” 覇FIG. 1(a) is a plan view of an ISFET for measuring vasobrenosine in one embodiment of the present invention, and FIG.
), FIG. 2(a) is a plan view of the Pasopressin reference 18FET, FIG. 2(b) is a sectional view along the 1-1' plane of FIG. The figure shows a measurement circuit diagram of the I 8 FET for detecting pasopressin of this example, and FIG. 4 shows the relationship between the concentration of vasobrenosine and the current between the source and drain. Engineering...P-type silicon, 2...Drain n region, 2'
...Source n region, 3...P-type channel, 4
... Channel stopper (P), 5... Drain electrode, 5'-Drain electrode Al terminal, 6... Source electrode, 6'8.・Source electrode AJ terminal, 7...SiO2
, 8... Si3N4.9... Mixed resin of epoxy and silicone, 10... Pasopressin monoclonal antibody solidified membrane, 11 Measurement pH-FET, 12... Reference p1 E-FET. 13 ・Ag/Ag (J reference pole, 24...differential amplifier. Name of agent: Patent attorney Shigetaka Awano and 1 other person No. 1
Figure (Q,) 10? i#C rise Figure 2 Figure 3 1δ ISF Hill T/2 Figure 4 PP” Conquest
Claims (1)
ト上にパゾプレッシンと抗体・抗原反応によって膜電位
が変わるパゾプレッシンモノクローナル抗体を固定化し
た膜でゲートを被覆した測定イオン感応性電界効果トラ
ンジスタと被覆しない参照イオン感応性電界効果トラン
ジスタを用意し、両者の補償した出力によってパゾプレ
ッシンの濃度を知ることを特徴とするパゾプレッシン検
出センサ。Measurement ion-sensitive field-effect transistor (ISFET) whose gate was coated with a membrane immobilized with a pasopressin monoclonal antibody whose membrane potential changes due to antibody-antigen reaction with pasopressin, and a reference ion-sensitive field-effect transistor without coating. 1. A pasopressin detection sensor, which is characterized in that it includes a magnetic field effect transistor and determines the concentration of pasopressin based on the compensated outputs of both.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1130831A JPH02309247A (en) | 1989-05-24 | 1989-05-24 | Vasopressin detection sensor |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1130831A JPH02309247A (en) | 1989-05-24 | 1989-05-24 | Vasopressin detection sensor |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH02309247A true JPH02309247A (en) | 1990-12-25 |
Family
ID=15043719
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP1130831A Pending JPH02309247A (en) | 1989-05-24 | 1989-05-24 | Vasopressin detection sensor |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH02309247A (en) |
-
1989
- 1989-05-24 JP JP1130831A patent/JPH02309247A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Karbue et al. | A microsensor for urea based on an ion-selective field effect transistor | |
US4334880A (en) | Analytical device having semiconductive polyacetylene element associated with analyte-binding substance | |
JP4195859B2 (en) | FET type sensor, ion concentration detection method and base sequence detection method using the sensor | |
EP0096095B1 (en) | Semiconductor device, sensor and method for determining the concentration of an analyte in a medium | |
Abdelshafi et al. | Microfluidic electrochemical immunosensor for the trace analysis of cocaine in water and body fluids | |
GB2236903A (en) | "FET sensor apparatus of flow-cell adaptive type and method of manufacturing the same" | |
Poghossian | Determination of the pHpzc of insulators surface from capacitance–voltage characteristics of MIS and EIS structures | |
Sant et al. | Development of a creatinine-sensitive sensor for medical analysis | |
Meyerhoff et al. | Electrode-based enzyme immunoassays using urease conjugates | |
Wehmeyer et al. | Electrochemical investigation of hapten-antibody interactions by differential pulse polarography. | |
US4839000A (en) | Buffer compensation in enzyme-modified ion sensitive devices | |
Jin et al. | Magnetic particle-based chemiluminescence enzyme immunoassay for free thyroxine in human serum | |
Wang et al. | Fabrication of BioFET linear array for detection of protein interactions | |
Van Der Schoot et al. | A flow injection analysis system with glass-bonded ISFETs for the simultaneous detection of calcium and potassium ions and pH | |
Miyahara et al. | Urea sensor based on an ammonium-ion-sensitive field-effect transistor | |
Hirst et al. | Electrodes in clinical chemistry | |
JPH02309247A (en) | Vasopressin detection sensor | |
Gotoh et al. | Immuno-FET sensor | |
JPH01212347A (en) | Method and apparatus for measuring very small amount of analyte substance | |
Sakai et al. | Availability and development of an enzyme immunomicrosensor based on an ISFET for human immunoglobulins | |
JPH02309246A (en) | Somatostatin detection sensor | |
JPS63208753A (en) | Immune sensor and immune detection | |
JPH02309241A (en) | Adrenalin detection sensor | |
JPH02309244A (en) | Serotonin detection sensor | |
JP2694809B2 (en) | Enzyme immunoassay method and enzyme immunosensor |